Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus (HIV) Infections”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00197704
What this trial is testing

Nutrition, Immunology and Epidemiology of Tuberculosis

Who this might be right for
Tuberculosis
Harvard School of Public Health (HSPH) 876
Post-approval studies (Phase 4)Study completedNCT00240552
What this trial is testing

Fosamprenavir Expanded Access

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 85
Not applicableStudy completedNCT04545164
What this trial is testing

Computer Aided Screening for Tuberculosis in Low Resource Environments

Who this might be right for
Tuberculosis InfectionHIV Infections
London School of Hygiene and Tropical Medicine 498
Testing effectiveness (Phase 2)UnknownNCT00622232
What this trial is testing

A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial

Who this might be right for
HIV Infections
VIRxSYS Corporation 40
Post-approval studies (Phase 4)Ended earlyNCT00414284
What this trial is testing

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

Who this might be right for
HIV Infections
Community Research Initiative of New England
Not applicableStudy completedNCT05377138
What this trial is testing

Evaluate and Optimize an Online Care Model for PrEP Delivery: Pilot Study

Who this might be right for
HIV Infections
University of Washington 2,357
Testing effectiveness (Phase 2)Study completedNCT00033163
What this trial is testing

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

Who this might be right for
HIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT05223114
What this trial is testing

Airway Microbiome and Th17-mediated Inflammation in COPD Among HIV-infected Individuals in a Rural Ugandan Cohort

Who this might be right for
COPDHIV InfectionsRespiratory Disease
Makerere University 160
Early research (Phase 1)Study completedNCT02430506
What this trial is testing

Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TB

Who this might be right for
Tuberculosis
Aeras 20
Not applicableStudy completedNCT04155684
What this trial is testing

Dysbiosis Impact on Lung Disease in HIV

Who this might be right for
HIV InfectionsCOPDMicrobiome
University of Pittsburgh 50
Not applicableStudy completedNCT05855655
What this trial is testing

Developing an Online Mindfulness-based Intervention to Reduce Minority Stress and HIV Risk Among Young Adult MSM - Aim 3

Who this might be right for
HivMinority StressMental Health Wellness 1
Brown University 68
Not applicableStudy completedNCT03835832
What this trial is testing

Self-Assessment Tuberculin Skin Test

Who this might be right for
Tuberculin Skin Test
The HIV Netherlands Australia Thailand Research Collaboration 215
Early research (Phase 1)Study completedNCT00001021
What this trial is testing

A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 57
Large-scale testing (Phase 3)Study completedNCT01900106
What this trial is testing

A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)

Who this might be right for
HIV Infection
University of Modena and Reggio Emilia 47
Large-scale testing (Phase 3)Not Yet RecruitingNCT06276504
What this trial is testing

Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection

Who this might be right for
Progressive Multifocal Leukoencephalopathy
Assistance Publique - Hôpitaux de Paris 33
Not applicableStudy completedNCT00703404
What this trial is testing

Response to Standard HIV Treatment in Bamako, Mali

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 76
Not applicableStudy completedNCT00904384
What this trial is testing

Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients

Who this might be right for
HIV InfectionsCOPD
Cimera 350
Not applicableStudy completedNCT04077138
What this trial is testing

Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Intervention Development

Who this might be right for
HIV/AIDSGenderBehavior and Behavior Mechanisms
Hektoen Institute for Medical Research 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05631093
What this trial is testing

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 553
Post-approval studies (Phase 4)UnknownNCT04746547
What this trial is testing

Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

Who this might be right for
TuberculosisHiv
University of KwaZulu 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation